Lexicon Pharmaceuticals Inc (LXRX) Implied Volatility Current

Tracking LXRX implied volatility helps you identify when options premiums on Lexicon Pharmaceuticals Inc are historically cheap or expensive, and where the best trades are hiding. Lexicon Pharmaceuticals Inc implied volatility reflects the market's expectation of future price movement: when LXRX IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor Lexicon Pharmaceuticals Inc's implied volatility current levels in real time and filter for high-probability trades.

Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For LXRX, tracking metrics like LXRX IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on LXRX signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.

Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; and LX9211, which is in Phase II clinical development for the treatment of neuropathic pain. The company has strategic collaboration and license agreements with Bristol-Myers Squibb Company, and Genentech, Inc. Lexicon Pharmaceuticals, Inc. was incorporated in 1995 and is headquartered in The Woodlands, Texas.

Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where LXRX implied volatility sits today versus where it has been. Our scanner ranks Lexicon Pharmaceuticals Inc implied volatility against its historical range, surfaces extremes in LXRX IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether Lexicon Pharmaceuticals Inc IV is rich or cheap — measure it, then act on it.